Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Here's What We Know About The Brewing Bidding War For Onyx Pharmaceuticals
Forbes
Mon, 07/1/13 - 12:44 pm
Amgen
M&A
ONYX Pharmaceuticals
Bayer
Pfizer
Onyx Pharma Is For Sale, for North of $10B
TheStreet.com
Mon, 07/1/13 - 11:48 am
M&A
ONYX Pharmaceuticals
Amgen
Sanofi
Pfizer
Onyx Jumps After Report Amgen Considers Acquisition
Bloomberg
Fri, 06/28/13 - 06:50 pm
Amgen
M&A
ONYX Pharmaceuticals
Nexavar
Has Illumina Set Its Sights On TrovaGene As Its Next Acquisition?
Seeking Alpha
Fri, 06/28/13 - 06:47 pm
M&A
Illumina
TrovaGene
Sequenom
Boston Scientific spends $275M on CR Bard business
Yahoo/AP
Fri, 06/28/13 - 12:20 pm
Boston Scientific
CR Bard
M&A
devices
Game may not be over for Royalty' Pharma's bid for Elan
Reuters
Thu, 06/27/13 - 08:59 pm
M&A
Elan
Royalty Pharma
Mylan
Allergan
Endo Health Solutions
Forest Labs
Sanofi, Novartis, GlaxoSmithKline reportedly circling India's Elder Pharma
Fierce Pharma
Thu, 06/27/13 - 11:51 am
India
Sanofi
Novartis
GSK
Elder Pharmaceuticals
M&A
Biocad Said to Seek Buyer in Sale That May Top $1 Billion - Bidders Include Pfizer and Amgen
Bloomberg
Thu, 06/27/13 - 10:40 am
Russia
Pfizer
M&A
Biocad
Amgen
New AMA Obesity Ruling Should Push Big Pharma To Find Acquisitions
Seeking Alpha
Thu, 06/27/13 - 09:59 am
obesity
M&A
Oramed
AstraZeneca
MannKind
Merck
Sanofi
Novo Nordisk
New drugs allow GSK disposals to 'far exceed' acquisitions
Reuters
Tue, 06/25/13 - 12:34 pm
GSK
M&A
Why Might This Play Shake Up the Cancer-Drug Industry?
Motley Fool
Tue, 06/25/13 - 10:41 am
cancer
JNJ
M&A
Aragon
prostate cancer
Tenet to Buy Vanguard Health for $1.8 Billion in Cash
Bloomberg
Mon, 06/24/13 - 10:58 am
TENET
Vanguard Health Systems
M&A
Glaxo Gets Offer for Thrombosis Drugs
Yahoo/Zacks
Thu, 06/20/13 - 07:36 am
GSK
thrombosis
M&A
Arixtra
Fraxiparine
Aspen Pharmacare
Forest Laboratories one of several suitors for Elan, report says
Marketwatch
Wed, 06/19/13 - 03:46 pm
Elan
Forest Labs
M&A
Japan's Astellas looks to sell dermatology assets - sources
Reuters
Wed, 06/19/13 - 11:16 am
Japan
dermatology
Astellas
M&A
Royalty Pharma lets takeover bid for drugmaker Elan expire, decides against court challenge
Yahoo/AP
Tue, 06/18/13 - 11:42 am
Elan
M&A
Royalty Pharma
BioScrip buying CarePoint for $223 million to expand at-home drug infusion business
Yahoo/AP
Tue, 06/18/13 - 08:58 am
CarePoint
BioScrip
M&A
at-home drug infusion
Teva buys MicroDose for $165 million
First Word
Mon, 06/17/13 - 12:54 pm
MicroDose Therapeutx
M&A
Teva
Medivation retreats after J&J beefs up prostate cancer slate
The Fly on the Wall
Mon, 06/17/13 - 12:37 pm
JNJ
M&A
Medivation
prostate cancer
Aragon
Zytiga
Orphan drugmaker ViroPharma attracts takeover interest: sources
Reuters
Mon, 06/17/13 - 11:52 am
ViroPharma
M&A
Biomarin
Pages
« first
‹ previous
…
225
226
227
228
229
230
231
232
233
…
next ›
last »